SCHEMBL9079588

SCHEMBL9079588

NC(=O)Cc1c(C(F)(F)F)nc2c(NC(=O)c3c(Cl)cccc3Cl)cccn12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CRHBP P24387 1/20 0.43
HTT P42858 1/20 0.43
CRHR2 Q13324 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TYK2 P29597 2/20 0.39
PTGES O14684 3/20 0.39
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36
HPGD P15428 1/20 0.36
CDK2 P24941 2/20 0.35
CDK1 P06493 1/20 0.35
CCNA2 P20248 1/20 0.35
HDAC2 Q92769 1/20 0.35
CYP1A2 P05177 1/20 0.35
JAK2 O60674 1/20 0.35
CYP3A4 P08684 1/20 0.35
JAK1 P23458 1/20 0.35
TLR7 Q9NYK1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9080565 0.91 MEN1 (0.43) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9081108 0.89 KMT2A (0.45) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9080031 0.89 KMT2A (0.45) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9082482 0.88 MEN1 (0.41) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9081483 0.88 KMT2A (0.44) MEN1KMT2ACRHBPHTTCRHR2
Hydrochloric Acid SCHEMBL9081496 0.88 MEN1 (0.44) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9081490 0.86 MEN1 (0.38) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9283353 0.86 KMT2A (0.43) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9229096 0.85 SMN1; SMN2 (0.39) MEN1KMT2ACRHBPHTTCRHR2
SCHEMBL9079941 0.85 MEN1 (0.42) MEN1KMT2ACRHBPHTTCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996034866-A1 IMIDAZO 1,2-A PYRIDINE AND IMIDAZO 1,2-A PYRIDEZINE DERIVATIVES AND THEIR USE AS BONE RESORPTION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-11-07 WO disclosed